#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Neurodermatitis Neuropathic arthropathy Autoimmune demyelinating disease Salivary gland cancer Lymphoma Hereditary angioedema Thymic carcinoma Graft versus host disease Extra-osseous Ewing's sarcoma Paget's disease of the vulva Cataract Cognitive disorder Myeloproliferative neoplasm Stiff person syndrome Heavy menstrual bleeding More trials…
Learn about Rare Diseases

Inclusion body myositis – Basic Information Hereditary motor and sensory neuropathy – Life with Disease Pulmonary sarcoidosis Medulloblastoma – Trials in Disease Osteosarcoma metastatic – Trials in Disease Kearns-Sayre syndrome – Diagnostics Short-bowel syndrome – Diagnostics Hereditary ataxia – Treatment Prolymphocytic leukaemia – Treatment MELAS syndrome – Treatment More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Fluorouracil Elranatamab Melphalan Hydrochloride Relatlimab ATIRMOCICLIB Rhh646 VERT-002 INSULIN DEGLUDEC Magrolimab Riliprubart S227928 Allo-647 Ngm707 Nebivolol Gsk3739937 Bupropion Hydrochloride Taurine Gskvx000000009151 Pbf-999 Magnesium Sulfate Heptahydrate More therapies…

Learn about Your Condition

Turner's syndrome Naevus flammeus Albuminuria Type 1 diabetes mellitus Neurodegenerative disorder Metastatic glioma Multiple system atrophy Primary adrenal insufficiency Spondylolisthesis Pyoderma Viral myocarditis Deafness traumatic Atrial flutter Fatty acid oxidation disorder Piriformis syndrome More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe
🇦🇹 Austria
🇭🇷 Croatia
🇨🇿 Czech Republic
🇩🇰 Denmark
🇪🇪 Estonia
🇫🇮 Finland
🇫🇷 France
🇩🇪 Germany
🇮🇸 Iceland
🇮🇹 Italy
🇱🇻 Latvia
🇱🇹 Lithuania
🇳🇱 Netherlands
🇳🇴 Norway
🇵🇱 Poland
🇵🇹 Portugal
🇷🇴 Romania
🇸🇰 Slovakia
🇸🇮 Slovenia
🇪🇸 Spain
🇸🇪 Sweden

Malignant neoplasm of unknown primary site

A Study of CLDN6 CAR-T Cell Therapy With or Without CLDN6 RNA-LPX Vaccine in Patients With CLDN6-Positive Advanced Solid Tumors That Returned or Did Not Respond to Treatment

Not recruiting

1 1 1
Investigated Drugs:
Study to Identify Unknown Primary Cancer Using [18F]-AlF-FAPI-74 PET-CT for Patients with Carcinoma of Unknown Primary

Not recruiting

3 1 1
Investigated Diseases:
- Malignant neoplasm of unknown primary site
Investigated Drugs:
- [Al[18F]F]Fapi-74
A Phase 1/2a Study of BNT142 Safety and Early Effectiveness in Patients with Advanced Solid Tumors Expressing CLDN6 Protein

Not recruiting

2 1 1

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Malignant neoplasm of unknown primary site

A Study of CLDN6 CAR-T Cell Therapy With or Without CLDN6 RNA-LPX Vaccine in Patients With CLDN6-Positive Advanced Solid Tumors That Returned or Did Not Respond to Treatment

Study to Identify Unknown Primary Cancer Using [18F]-AlF-FAPI-74 PET-CT for Patients with Carcinoma of Unknown Primary

A Phase 1/2a Study of BNT142 Safety and Early Effectiveness in Patients with Advanced Solid Tumors Expressing CLDN6 Protein

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies